2025-09-12T15:54:33+00:00 2023-12-31 440160260 Forvis Mazars LLP 500 Ridgefield Court Asheville NC 28806 990PF 2023-01-01 274355411 The Amnion Foundation Inc AMNI 3369552241 111 N Chestnut Street Ste 100 WinstonSalem NC 27101 Anna Smith EXECUTIVE DIRECTOR 2025-09-12 true Amy Bibby P00445891 8282542254 2025-09-11 2023 2025-03-06 01:10:19Z X 325673 X 125 X 202 202 202 1516 1516 1516 -5231 1547 0 0 447391 11774 435617 435617 0 0 0 432229 1718 437335 283656 100000 183656 28012 13843 14169 10179 0 0 10179 8655 0 0 8655 58594 2600 0 55994 21951 0 0 21920 88302 0 0 63870 51096 12774 15286 15286 380204 0 323774 56430 958709 2600 488713 379063 0 0 958709 2600 488713 379063 -526480 0 0 17532 13256 13256 0 0 0 0 0 0 0 0 0 0 0 0 0 4270 4070 4070 0 0 0 0 0 0 0 0 0 0 0 0 95921 0 0 1266625 975020 359437 291605 291605 19332 16742 16742 496492 325673 325673 5913 77749 0 0 0 275000 5913 352749 490579 -27076 490579 -27076 496492 325673 490579 -526480 8825 -27076 0 -27076 Realized Gains/Losses P 1547 6778 -5231 0 -5231 -5231 0 0 0 0 0 0 0 0 false false false 0 0 0 false false false false false true NC true true false false false true WWW.AMNIONFOUNDATION.ORG The Organization 3369552241 111 N CHESTNUT STREET STE 100 WinstonSalem NC 27101 false false false false false false false false false false false false false false false false false false false false false ALAN RETICK 111 N Chestnut Street WinstonSalem NC 27101 DIRECTOR 3.000 0 0 0 ROGER DEFILLIPO 111 N Chestnut Street WinstonSalem NC 27101 DIRECTOR 3.000 0 0 0 Dr Anthony Atala 111 N Chestnut Street WinstonSalem NC 27101 DIRECTOR 3.000 0 0 0 Arthur NeJame 111 N Chestnut Street WinstonSalem NC 27101 DIRECTOR 3.000 0 0 0 Anna G Smith 111 N Chestnut Street WinstonSalem NC 27101 Executive Director 40.000 106167 4287 0 Jessica K Cheu 111 N Chestnut Street WinstonSalem NC 27101 Lead Biomed. Engr. 40.000 76481 3246 0 2 Through the end of 2015, the Amnion Foundation had developed a detailed plan to build a public stem cell bank. In 2016, the Foundation shifted into execution mode, completing the build out of its cleanroom and banking facility, hiring it's first technician, and an executive director. The Foundation also began to assemble the appropriate Quality Assurance infrastructure to allow FDA compliant tissue banking processes. BY the end of 2016, the Foundation was receiving the first tissue samples for training purposes and regulatory validation runs. This positions the Foundation to begin banking tissues for human clinical use in 2017. The Foundation continued these operations through 2018, 2019, 2020, 2021, 2022, and 2023. 619568 0 27622 30400 0 58022 0 58022 870 57152 2858 X 379063 0 0 379063 X 0 0 31141 0 31141 0 0 26470 0 26470 379063 340592 626415 971862 2317932 0 0 0 0 0 379063 340592 626415 971862 2317932 325673 496492 876891 1454605 3153661 325673 496492 850199 1437191 3109555 X 0 0 14 202 14 1516 18 -5231 435617 0 -3513 435617 432104 10 REVENUE EARNED FROM STEM CELL RESEARCH SERVICES false false false false false false false false false false ACCOUNTING FEES 8655 8655 88302 INVESTMENT ACCOUNT AT COST Buildings and equipment 1266625 975020 291605 291605 legal fees 10179 10179 0 Anthony Atala DIRECTOR DIRECTOR 50000 50000 2023-07 2026-07 Monthly 0.0 NONE OPERATIONS CASH 50000 Anthony Atala DIRECTOR DIRECTOR 50000 50000 2023-08 2026-08 Monthly 0.0 NONE OPERATIONS CASH 50000 Anthony Atala DIRECTOR DIRECTOR 50000 50000 2023-09 2026-09 Monthly 0.0 NONE OPERATIONS CASH 50000 Anthony Atala DIRECTOR DIRECTOR 75000 75000 2023-11 2026-11 Monthly 0.0 NONE OPERATIONS CASH 75000 Anthony Atala DIRECTOR DIRECTOR 50000 50000 2026-12 2026-12 Monthly 0.0 NONE OPERATIONS CASH 50000 SECURITY DEPOSITS 3100 3100 3100 SALES TAX RECEIVABLE 15267 12677 12677 Receivables from Officers 965 965 965 MISCELLANEOUS EXPENSE 11132 11132 INTEREST EXPENSE 5394 5394 INSURANCE EXPENSE 5936 5936 OFFICE EXPENSES 13815 13815 BANK SERVICE CHARGES 4195 4195 LAB EXPENSES 323774 323774 Employee Expenses 5000 5000 Sponsorships 2500 2500 Advertising/Promotional 7384 7384 Payroll Processing Charges 1074 1074 UNREALIZED GAIN/LOSS 8825 CONSULTING FEES 55994 55994 Investment Fee 2600 2600 Gross sales 447391 447391 Shipping COGS 11774 -11774 PAYROLL TAXES 21920 21920 Federal Tax Expense 31